Literature DB >> 35289912

Developing a COVID-19 WHO Clinical Progression Scale inpatient database from electronic health record data.

Priya Ramaswamy1,2, Jen J Gong3, Sameh N Saleh4,5,6, Samuel A McDonald4,7, Seth Blumberg8,9,10, Richard J Medford4,11, Xinran Liu1.   

Abstract

OBJECTIVE: There is a need for a systematic method to implement the World Health Organization's Clinical Progression Scale (WHO-CPS), an ordinal clinical severity score for coronavirus disease 2019 patients, to electronic health record (EHR) data. We discuss our process of developing guiding principles mapping EHR data to WHO-CPS scores across multiple institutions.
MATERIALS AND METHODS: Using WHO-CPS as a guideline, we developed the technical blueprint to map EHR data to ordinal clinical severity scores. We applied our approach to data from 2 medical centers.
RESULTS: Our method was able to classify clinical severity for 100% of patient days for 2756 patient encounters across 2 institutions. DISCUSSION: Implementing new clinical scales can be challenging; strong understanding of health system data architecture was integral to meet the clinical intentions of the WHO-CPS.
CONCLUSION: We describe a detailed blueprint for how to apply the WHO-CPS scale to patient data from the EHR.
© The Author(s) 2022. Published by Oxford University Press on behalf of the American Medical Informatics Association. All rights reserved. For permissions, please email: journals.permissions@oup.com.

Entities:  

Keywords:  COVID-19; World Health Organization; electronic health records; medical informatics; public health informatics

Mesh:

Year:  2022        PMID: 35289912      PMCID: PMC9196693          DOI: 10.1093/jamia/ocac041

Source DB:  PubMed          Journal:  J Am Med Inform Assoc        ISSN: 1067-5027            Impact factor:   7.942


  10 in total

1.  A Retrospective Review of Angiotensin II Use in Adult Patients With Refractory Distributive Shock.

Authors:  Adrian Wong; Afrah Alkazemi; I Mary Eche; Camille R Petri; Todd Sarge; Michael N Cocchi
Journal:  J Intensive Care Med       Date:  2019-09-03       Impact factor: 3.510

2.  Erratum: Author Correction: The reproducibility crisis in the age of digital medicine.

Authors:  Aaron Stupple; David Singerman; Leo Anthony Celi
Journal:  NPJ Digit Med       Date:  2019-03-19

3.  Data sharing for novel coronavirus (COVID-19).

Authors:  Vasee Moorthy; Ana Maria Henao Restrepo; Marie-Pierre Preziosi; Soumya Swaminathan
Journal:  Bull World Health Organ       Date:  2020-03-01       Impact factor: 9.408

4.  Methylene blue administration in patients with refractory distributive shock - a retrospective study.

Authors:  Michal Porizka; Petr Kopecky; Helena Dvorakova; Jan Kunstyr; Michal Lips; Pavel Michalek; Martin Balik
Journal:  Sci Rep       Date:  2020-02-04       Impact factor: 4.379

5.  Obtaining EHR-derived datasets for COVID-19 research within a short time: a flexible methodology based on Detailed Clinical Models.

Authors:  Miguel Pedrera-Jiménez; Noelia García-Barrio; Jaime Cruz-Rojo; Ana Isabel Terriza-Torres; Elena Ana López-Jiménez; Fernando Calvo-Boyero; María Jesús Jiménez-Cerezo; Alvar Javier Blanco-Martínez; Gustavo Roig-Domínguez; Juan Luis Cruz-Bermúdez; José Luis Bernal-Sobrino; Pablo Serrano-Balazote; Adolfo Muñoz-Carrero
Journal:  J Biomed Inform       Date:  2021-02-03       Impact factor: 6.317

Review 6.  Health informatics and EHR to support clinical research in the COVID-19 pandemic: an overview.

Authors:  Arianna Dagliati; Alberto Malovini; Valentina Tibollo; Riccardo Bellazzi
Journal:  Brief Bioinform       Date:  2021-03-22       Impact factor: 11.622

7.  Correction: A flexible method for optimising sharing of healthcare resources and demand in the context of the COVID-19 pandemic.

Authors:  Lucas Lacasa; Robert Challen; Ellen Brooks-Pollock; Leon Danon
Journal:  PLoS One       Date:  2021-04-29       Impact factor: 3.240

Review 8.  A minimal common outcome measure set for COVID-19 clinical research.

Authors: 
Journal:  Lancet Infect Dis       Date:  2020-06-12       Impact factor: 25.071

Review 9.  COVID-19 and Respiratory System Disorders: Current Knowledge, Future Clinical and Translational Research Questions.

Authors:  Shari B Brosnahan; Annemijn H Jonkman; Matthias C Kugler; John S Munger; David A Kaufman
Journal:  Arterioscler Thromb Vasc Biol       Date:  2020-09-22       Impact factor: 8.311

10.  Core Outcome Measures for Trials in People With Coronavirus Disease 2019: Respiratory Failure, Multiorgan Failure, Shortness of Breath, and Recovery.

Authors:  Allison Tong; Amanda Baumgart; Nicole Evangelidis; Andrea K Viecelli; Simon A Carter; Luciano Cesar Azevedo; Tess Cooper; Andrew Bersten; Lilia Cervantes; Derek P Chew; Sally Crowe; Ivor S Douglas; Ella Flemyng; Julian H Elliott; Elyssa Hannan; Peter Horby; Martin Howell; Angela Ju; Jaehee Lee; Eduardo Lorca; Deena Lynch; Karine E Manera; John C Marshall; Andrea Matus Gonzalez; Anne McKenzie; Sangeeta Mehta; Mervyn Mer; Andrew Conway Morris; Dale M Needham; Saad Nseir; Pedro Povoa; Mark Reid; Yasser Sakr; Ning Shen; Alan R Smyth; A John Simpson; Tom Snelling; Giovanni F M Strippoli; Armando Teixeira-Pinto; Antoni Torres; Tari Turner; Steve Webb; Paula R Williamson; Laila Woc-Colburn; Junhua Zhang; Jonathan C Craig
Journal:  Crit Care Med       Date:  2021-03-01       Impact factor: 9.296

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.